Whitehawk Therapeutics, Inc. (WHWK)
4.05
-0.15
(-3.57%)
USD |
NASDAQ |
Sep 21, 16:00
4.05
0.00 (0.00%)
After-Hours: 20:00
Whitehawk Therapeutics Price to Book Value : 1.262 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.309 |
| September 17, 2026 | 1.272 |
| September 16, 2026 | 1.259 |
| September 15, 2026 | 1.275 |
| September 14, 2026 | 1.268 |
| September 11, 2026 | 1.281 |
| September 10, 2026 | 1.268 |
| September 09, 2026 | 1.306 |
| September 08, 2026 | 1.368 |
| September 04, 2026 | 1.434 |
| September 03, 2026 | 1.443 |
| September 02, 2026 | 1.468 |
| September 01, 2026 | 1.443 |
| August 31, 2026 | 1.415 |
| August 28, 2026 | 1.440 |
| August 27, 2026 | 1.518 |
| August 26, 2026 | 1.508 |
| August 25, 2026 | 1.583 |
| August 24, 2026 | 1.521 |
| August 21, 2026 | 1.474 |
| August 20, 2026 | 1.505 |
| August 19, 2026 | 1.518 |
| August 18, 2026 | 1.484 |
| August 17, 2026 | 1.446 |
| August 14, 2026 | 1.39 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.458 |
| August 12, 2026 | 1.468 |
| August 11, 2026 | 1.455 |
| August 10, 2026 | 1.418 |
| August 07, 2026 | 1.484 |
| August 06, 2026 | 1.465 |
| August 05, 2026 | 1.268 |
| August 04, 2026 | 1.290 |
| August 03, 2026 | 1.234 |
| July 31, 2026 | 1.200 |
| July 30, 2026 | 1.200 |
| July 29, 2026 | 1.141 |
| July 28, 2026 | 1.147 |
| July 27, 2026 | 1.153 |
| July 24, 2026 | 1.156 |
| July 23, 2026 | 1.194 |
| July 22, 2026 | 1.244 |
| July 21, 2026 | 1.219 |
| July 20, 2026 | 1.181 |
| July 17, 2026 | 1.212 |
| July 16, 2026 | 1.212 |
| July 15, 2026 | 1.200 |
| July 14, 2026 | 1.187 |
| July 13, 2026 | 1.197 |
| July 10, 2026 | 1.237 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.20 |
| Anika Therapeutics, Inc. | 2.020 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.582 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0025 |
| Price | 4.05 |
| Earnings Yield | -27.50% |
| Market Cap | 230.89M |
| PEGY Ratio | -0.0025 |